Estrogen receptor α, but not β, plays a major role in 17β-estradiol-induced murine cholesterol gallstones

Gastroenterology - Tập 127 - Trang 239-249 - 2004
Helen H. Wang1, Nezam H. Afdhal1, David Q.-H. Wang1
1Department of Medicine, Liver Center and Gastroenterology Division, Beth Israel Deaconess Medical Center, Harvard Medical School and Harvard Digestive Diseases Center, Boston, Massachusetts, USA

Tài liệu tham khảo

Paigen, 2002, Gallstones, 298 Diehl, 1991, Epidemiology and natural history of gallstone disease, Gastroenterol Clin North Am, 20, 1, 10.1016/S0889-8553(21)00531-8 1973, Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours, Lancet, 1, 1399 Bennion, 1976, Effects of oral contraceptives on the gallbladder bile of normal women, N Engl J Med, 294, 189, 10.1056/NEJM197601222940403 1974, Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy, N Engl J Med, 290, 15, 10.1056/NEJM197401032900104 Grodstein, 1994, Postmenopausal hormone use and cholecystectomy in a large prospective study, Obstet Gynecol, 83, 5 Uhler, 2000, Estrogen replacement therapy and gallbladder disease in postmenopausal women, Menopause, 7, 162, 10.1097/00042192-200007030-00006 Simon, 2001, Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/Progestin Replacement Study, Ann Intern Med, 135, 493, 10.7326/0003-4819-135-7-200110020-00008 Henriksson, 1989, Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma, J Clin Invest, 84, 811, 10.1172/JCI114240 Angelin, 1992, Hepatic cholesterol metabolism in estrogen-treated men, Gastroenterology, 103, 1657, 10.1016/0016-5085(92)91192-7 Gruber, 2002, Production and action of estrogens, N Engl J Med, 346, 340, 10.1056/NEJMra000471 Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β, Endocrinology, 138, 863, 10.1210/en.138.3.863 Mangelsdorf, 1995, The nuclear receptor superfamily, Cell, 83, 835, 10.1016/0092-8674(95)90199-X Katzenellenbogen, 2000, Molecular mechanisms of estrogen action, J Steroid Biochem Mol Biol, 74, 279, 10.1016/S0960-0760(00)00104-7 Iavarone, 2003, The clinical and pathogenetic significance of estrogen receptor-β expression in chronic liver diseases and liver carcinoma, Cancer, 98, 529, 10.1002/cncr.11528 Kraichely, 2000, Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β, Endocrinology, 141, 3534, 10.1210/en.141.10.3534 Stauffer, 2000, Pyrazole ligands, J Med Chem, 43, 4934, 10.1021/jm000170m Harris, 2002, Characterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand, Endocrinology, 143, 4172, 10.1210/en.2002-220403 Meyers, 2001, Estrogen receptor-β potency-selective ligands, J Med Chem, 44, 4230, 10.1021/jm010254a Howell, 2000, ICI 182,780 (Faslodex), Cancer, 89, 817, 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6 Hyder, 1997, Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780, Cancer Res, 57, 2547 Wakeling, 1991, A potent specific pure antiestrogen with clinical potential, Cancer Res, 51, 3867 Watanabe, 1997, Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype, Biochem Biophys Res Commun, 236, 140, 10.1006/bbrc.1997.6915 Luo, 1997, Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice, Int J Cancer, 73, 381, 10.1002/(SICI)1097-0215(19971104)73:3<381::AID-IJC13>3.0.CO;2-G Wang, 1997, Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice, J Lipid Res, 38, 1395, 10.1016/S0022-2275(20)37422-8 Wang, 2002, Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice, J Lipid Res, 43, 1950, 10.1194/jlr.M200078-JLR200 Wang, 1997, Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice, J Lipid Res, 40, 2066, 10.1016/S0022-2275(20)32430-5 Wang, 2003, Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption, Am J Physiol, 285, G494 Wang, 2002, Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI, Biochim Biophys Acta, 1583, 141, 10.1016/S1388-1981(02)00194-4 Rossi, 1987, High pressure liquid chromatographic analysis of conjugated bile acids in human bile, J Lipid Res, 28, 589, 10.1016/S0022-2275(20)38684-3 Bartlett, 1959, Phosphorous assay in column chromatography, J Biol Chem, 234, 466, 10.1016/S0021-9258(18)70226-3 Carey, 1978, Critical tables for calculating the cholesterol saturation of native bile, J Lipid Res, 19, 945, 10.1016/S0022-2275(20)40677-7 Akin, 2003, Tamoxifen and gallstone formation in postmenopausal breast cancer patients, World J Surg, 27, 395, 10.1007/s00268-002-6468-4 Couse, 1999, Estrogen receptor null mice, Endocr Rev, 20, 358, 10.1210/er.20.3.358 Ohashi, 2002, 17β-Estradiol increases cholesterol cholelithogenesis in gallstone-resistant mice through mediating the expression of hepatic lipid transporters, Gastroenterology, 122, A7 Wang, 2003, The blockade of estrogen action by Fulvestrant (ICI 182,780) prevents cholesterol gallstone formation in the mouse, Hepatology, 38, 195A, 10.1016/S0270-9139(03)80126-X Everson, 1991, Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism, J Clin Invest, 87, 237, 10.1172/JCI114977 Kern, 1987, Contraceptive steroids increase cholesterol in bile, J Lipid Res, 28, 828, 10.1016/S0022-2275(20)38650-8 Reichen, 1987, Cholesterol synthesis in the perfused liver of pregnant hamsters, J Lipid Res, 28, 1046, 10.1016/S0022-2275(20)38615-6 Wang, 2004, Overexpression of estrogen receptor α inhibits the negative feedback regulation of hepatic cholesterol biosynthesis and increases newly synthesized cholesterol leading to biliary cholesterol hypersecretion, Gastroenterology, 126, A673 Ranelletti, 1991, Estrogen and progesterone receptors in the gallbladders from patients with gallstones, Hepatology, 14, 608 Singletary, 1986, Estrogen and progesterone receptors in human gallbladder, Hepatology, 6, 574, 10.1002/hep.1840060405 Yamamoto, 1990, Immunohistochemical analysis of estrogen receptors in human gallbladder, Acta Pathol Jpn, 40, 14 Kern, 1981, Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle, J Clin Invest, 68, 1229, 10.1172/JCI110369 Kern, 1982, Biliary lipids, bile acids, and gallbladder function in the human female, J Lab Clin Med, 99, 798 Keane, 1986, Effects of age, gender and female sex hormones upon contractility of the human gallbladder in vitro, Surg Gynecol Obstet, 163, 555 Radberg, 1989, The influence of pregnancy and contraceptive steroids on the biliary tract and its reference to cholesterol gallstone formation, Scand J Gastroenterol, 25, 97, 10.3109/00365529009107929 Nawaz, 1999, Proteasome-dependent degradation of the human estrogen receptor, Pro Natl Acad Sci U S A, 96, 1858, 10.1073/pnas.96.5.1858 Alarid, 1999, Proteasome-mediated proteolysis of estrogen receptor, Mol Endocrinol, 13, 1522, 10.1210/me.13.9.1522 Preisler-Mashek, 2002, Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-α, Am J Physiol, 282, E891